Allogene Therapeutics: Q1 Earnings Snapshot

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Allogene Therapeutics Inc. (ALLO) on Wednesday reported a loss of $98.7 million in its first quarter.

The South San Francisco, California-based company said it had a loss of 68 cents per share.

The results missed Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for a loss of 63 cents per share.

The immuno-oncology company posted revenue of $52,000 in the period.

Allogene Therapeutics shares have fallen 9% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $5.72, a fall of 37% in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on ALLO at

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up